Lihi Zaks
research associate Novo Nordisk
Lihi Zaks is a lipid nanoparticle (LNP) formulation researcher at Novo Nordisk. Her work focuses on automation-assisted screening of novel LNP components for hepatic and extrahepatic delivery. As such, she has validated new methods to increase throughput of screening workflows and contributed to novel component design. In addition, she has optimized bioconjugation formulations for active targeting approaches and various cargo formats. She earned her BSE in Bioengineering from the University of Pennsylvania and furthered her studies at Tufts University School of Medicine, where she earned a Masters in Science.
Seminars
Wednesday 3rd June 2026
Improved High-throughput Screening for Safer & More Effective Extrahepatic LNP Delivery
3:10 pm
- Defining the design space: composition and component variations and their impacts in LNP delivery
- Defining the funnel: Formulation and in vitro considerations
- Automation assistance: Increasing throughput while maintaining particle and data quality
